Searchable abstracts of presentations at key conferences in endocrinology

ea0059p114 | Neoplasia, cancer & late effects | SFEBES2018

The analytical validation and clinical implications of introducing a chromogranin A referral service within Scotland

Wadsworth John , Smith Karen

Background: Chromogranin A is an acidic 48 kDa glycoprotein originating from the chromaffin granules of most neuroendocrine cell types. In health chromogranin A is released as a pro-hormone together with other peptide hormones in response to stimulation. In disease larger quantities of Chromogranin A are produced by neuroendocrine derived tumours thus allowing its use as a tumour marker. Due to the different clinical scenarios for measuring Chromogranin A requesting practices ...